Comparison of efficacy of Salmonella typhimurium A1-R and chemotherapy on stem-like and non-stem human pancreatic cancer cells

被引:73
作者
Hiroshima, Yukihiko [1 ,2 ,3 ]
Zhao, Ming [1 ]
Zhang, Yong [1 ]
Maawy, Ali [2 ]
Hassanein, Mohamed K. [1 ]
Uehara, Fuminari [1 ,2 ]
Miwa, Shinji [1 ,2 ]
Yano, Shuya [1 ,2 ]
Momiyama, Masashi [3 ]
Suetsugu, Atsushi [1 ,2 ,4 ]
Chishima, Takashi [3 ]
Tanaka, Kuniya [3 ]
Bouvet, Michael [2 ]
Endo, Itaru [3 ]
Hoffman, Robert M. [1 ,2 ]
机构
[1] AntiCanc Inc, San Diego, CA USA
[2] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA
[3] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan
[4] Gifu Univ, Grad Sch Med, Gifu, Japan
关键词
METASTATIC MOUSE MODELS; TUMOR-TARGETING MUTANT; NUDE-MICE;
D O I
10.4161/cc.25872
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The XPA1 human pancreatic cancer cell line is dimorphic, with spindle stem-like cells and round non-stem cells. We report here the in vitro IC50 values of stem-like and non-stem XPA1 human pancreatic cells cells for: (1) 5-fluorouracil (5-FU), (2) cisplatinum (CDDP), (3) gemcitabine (GEM), and (4) tumor-targeting Salmonella typhimurium A1-R (A1-R). IC50 values of stem-like XPA1 cells were significantly higher than those of non-stem XPA1 cells for 5-FU (P = 0.007) and CDDP (P = 0.012). In contrast, there was no difference between the efficacy of A1-R on stem-like and non-stem XPA1 cells. In vivo, 5-FU and A1-R significantly reduced the tumor weight of non-stem XPA1 cells (5-FU; P = 0.028; A1-R; P = 0.011). In contrast, only A1-R significantly reduced tumor weight of stem-like XPA1 cells (P = 0.012). The combination of A1-R with 5-FU improved the antitumor efficacy compared with 5-FU monotherapy on the stem-like cells (P = 0.004). The results of the present report indicate A1-R is a promising therapy for chemo-resistant pancreatic cancer stem-like cells. © 2013 Landes Bioscience.
引用
收藏
页码:2774 / 2780
页数:7
相关论文
共 22 条
[1]   Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models [J].
Bouvet, M ;
Yang, M ;
Nardin, S ;
Wang, X ;
Jiang, P ;
Baranov, E ;
Moossa, AR ;
Hoffman, RM .
CLINICAL & EXPERIMENTAL METASTASIS, 2000, 18 (03) :213-218
[2]  
Bouvet M, 2002, CANCER RES, V62, P1534
[3]   In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases [J].
Bouvet, Michael ;
Tsuji, Kazuhiko ;
Yang, Meng ;
Jiang, Ping ;
Moossa, Abdool R. ;
Hoffman, Robert M. .
CANCER RESEARCH, 2006, 66 (23) :11293-11297
[4]   A METASTATIC NUDE-MOUSE MODEL OF HUMAN PANCREATIC-CANCER CONSTRUCTED ORTHOTOPICALLY WITH HISTOLOGICALLY INTACT PATIENT SPECIMENS [J].
FU, XY ;
GUADAGNI, F ;
HOFFMAN, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5645-5649
[5]  
FURUKAWA T, 1993, CANCER RES, V53, P3070
[6]   TRIMMED SPEARMAN-KARBER METHOD FOR ESTIMATING MEDIAN LETHAL CONCENTRATIONS IN TOXICITY BIOASSAYS [J].
HAMILTON, MA ;
RUSSO, RC ;
THURSTON, RV .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 1977, 11 (07) :714-719
[7]   Stem-Like and Non-Stem Human Pancreatic Cancer Cells Distinguished by Morphology and Metastatic Behavior [J].
Hassanein, Mohamed K. ;
Suetsugu, Atsushi ;
Saji, Shigetoyo ;
Moriwaki, Hisataka ;
Bouvet, Michael ;
Moossa, A. R. ;
Hoffman, Robert M. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2011, 112 (12) :3549-3554
[8]   Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: A bridge to the clinic [J].
Hoffman, RM .
INVESTIGATIONAL NEW DRUGS, 1999, 17 (04) :343-359
[9]   Subcellular imaging in the live mouse [J].
Hoffman, Robert M. ;
Yang, Meng .
NATURE PROTOCOLS, 2006, 1 (02) :775-782
[10]   Bugging Tumors [J].
Hoffman, Robert M. .
CANCER DISCOVERY, 2012, 2 (07) :588-590